WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: MARCH ISSUE PUBLISHED

    March 2024 Issue has been successfully launched on 1 March 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PREVALENCE OF CYTOLOGICAL ABNORMALITY OF CERVICAL PAPANICOLAOU SMEAR IN A- IMAMEEN AL- KADYMIAN MEDICAL CITY 2020, 2021

*Dr. Zainab Alaa Dhari, Dr. Alhan H. Sultan, Dr. Lamees Adnan Shubber, Dr. Ilham Abdulrahman Alzubaidi and Dr. Hiba D. Al_Ameri

ABSTRACT

Introduction: Cervical cancer is one of the leading causes of cancer death among females worldwide and its behavior epidemiologically likes a venereal disease of low infectiousness. The wide differences in the incidence among different countries also influenced by the introduction of screening.It is one of seven malignancies that accounted for half of the yearly worldwide incidence and mortality burden of all cancers. The goal of this study is to find out how many Iraqi women have invasive cervical cancer and intraepithelial neoplasia. Method: A cross sectional study. Information including the age and cytological results of the Pap smear for each patient parity,history of wart,education level, were taken. Asymptomatic female and those having (post cotal bleeding, post-menopausal bleeding, inter menstrual bleeding, vaginal discharge, dyspareunia, warts) are included in the study. Any females with unsatisfactory in cytology, pap smear reports are excluded from study. Results: from 438 females, 383 (87%) females had normal diagnoses, 43 (10%) of females diagnosed as ASCUS and 12 (3%) as LSIL. Mean age of females according to diagnosis as following: LSIL (38.75 ± 12.55), ASCUS (41.93 ± 11.03) years. There is a significant association between Pap smear and outcome; 91.7% of females diagnosed as LSIL had never had a Pap smear. There is a significant association between wart history and result; 83.3% of LSIL and 76.7% of ASCUS females had never had a wart. Menopause is associated with outcome; 33.3% of LSIL and 30.2% of ASCUS patients had menopause. There is a strong correlation between contraceptive method and result; 66.7% of LSIL females use a combination CP, whereas 30.2% of females diagnosed as ASCUS are use hormonal CP. Conclusion: Most of females have cervical cancer screening diagnosed as ASCUS and then as LSIL, the age of females according to diagnosis outcomes as the following; LSIL (38.75 ± 12.55) years, ASCUS (41.93 ± 11.03) years. High frequency of LSIL among women do not do Pap smear previously.

[Full Text Article] [Download Certificate]